Oxford Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$408K Sell
9,549
-49,739
-84% -$2.7M 0.2% 141
2026
Q1
$3.72M Buy
59,288
+54,399
+1,113% +$4.35M 1.5% 3
2025
Q4
$466K Sell
4,889
-521
-10% -$51.1K 0.16% 208
2025
Q3
$528K Buy
+5,410
New +$560K 0.17% 194
2024
Q1
Sell
-12,214
Closed -$706K 273
2023
Q4
$706K Buy
+12,214
New +$652K 1.06% 19
2018
Q4
Sell
-26,215
Closed -$1.01M 1797
2018
Q3
$1.01M Sell
26,215
-6,021
-19% -$210K 0.02% 1009
2018
Q2
$1.05M Sell
32,236
-6,924
-18% -$209K 0.02% 1015
2018
Q1
$1.07M Sell
39,160
-29,237
-43% -$795K 0.02% 912
2017
Q4
$1.73M Buy
+68,397
New +$1.89M 0.04% 654
2014
Q2
Sell
-155,359
Closed -$2.1M 700
2014
Q1
$2.1M Buy
+155,359
New +$2.04M 0.06% 352
2013
Q3
Sell
-287,599
Closed -$2.67M 799
2013
Q2
$2.67M Buy
+287,599
New +$2.44M 0.07% 406

Other funds holding BSX

Oxford Asset Management's BSX Position: Q2 2026 in Review

Oxford Asset Management reduced its Boston Scientific (BSX) stake by 84% in Q2 2026, selling an estimated $2.7M and leaving 9,549 shares worth $408K. The position accounts for 0.2% of the portfolio, ranked #141.

Oxford Asset Management first reported a position in BSX in Q2 2013 and has held it in 11 quarters since. The position peaked at $3.72M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Oxford Asset Management held 9,549 shares of Boston Scientific worth $408K as of Q2 2026.
  • Oxford Asset Management sold 49,739 Boston Scientific shares in Q2 2026, an estimated $2.7M.
  • Boston Scientific made up 0.2% of Oxford Asset Management's portfolio in Q2 2026, its #141 holding.
  • Oxford Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 11 quarters since.
  • Oxford Asset Management's Boston Scientific position peaked at $3.72M in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.